Immunotherapy drug development pipeline continues significant growth in 2020 despite global pandemic impact.
Cancer Research Institute goes virtual for its Immunotherapy Patient Summit Series,
connecting patients and caregivers with leading experts in cancer immunotherapy.
Cancer Research Institute announces recipients of 2020 philanthropy and science awards to be presented at virtual gala, Innovators in Science and Philanthropy.
Cancer Research Institute awards $30.2 million in grants and fellowships to support basic and clinical research in immunology and cancer immunotherapy.
The Phase 2 clinical trial will analyze blood-based biomarkers versus conventional radiography for cancer patients treated with immunotherapy; findings could change direction of lung cancer treatment
*Immunotherapy results may vary from patient to patient.
Cancer Research Institute | National Headquarters
29 Broadway, Floor 4 | New York, NY 10006-3111
This September for Blood Cancer Awareness Month, we look at how we’re working toward a future immune to leukemia, lymphoma, and multiple myeloma.
The latest results from a variety of immunotherapy trials will be revealed during the ESMO Virtual Congress 2020 starting September 19.